RecruitingNot ApplicableNCT07282444

A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial

Collaborative Oncology Between Radiologists and Radiation Oncologists for the Evaluation of Contoured Targets (CORRECT)


Sponsor

Wake Forest University Health Sciences

Enrollment

194 participants

Start Date

Feb 20, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial tests a new way to share radiation therapy plans using the Collaborative Oncology between Radiologists and Radiation oncologists for the Evaluation of Contoured Targets (CORRECT) workflow to improve communication and collaboration between radiation oncologists (ROs) and radiologists when determining cancer targets for radiation treatment. Systemic barriers limit critical communication between radiation oncologists and radiologists and can lead to both under and overdosing of radiation therapy (RT) tumor targets and failures to properly interpret post-treatment imaging. The limited formal diagnostic radiology training of many providers can make differentiating normal from disease imaging findings during target determination difficult, especially in complex disease sites like the lung, head, and neck. Inaccurate target determination may result in cancer return, excess toxicity, or both. Likewise, radiologists who cannot access prior RT plans may mistake expected RT changes for recurrent cancer or overlook true progression. The CORRECT workflow was developed by ROs and radiologists to address RO-radiology communication barriers by facilitating sharing of comprehensive RT target contours during RT planning. The CORRECT workflow begins with the normal process of RO target contouring. Computed tomography (CT) images are then fused with RT targets and pushed to a pre-designated Picture Archiving and Communications System (PACS) software folder accessible by the radiology department. The radiologist can then review the fused images at their chosen time and annotate images to indicate potential deviations (e.g., not avoiding normal tissue or not including all tumor). The RO reviews the annotated images and decides if any changes to treatment targets are needed for the final treatment plan. Through this independent, asynchronous review of high-quality images, CORRECT overcomes many of the limitations of existing communication methods between RO-radiologist, fostering a more collaborative, efficient, and precise approach to cancer treatment planning.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new system for sharing radiation therapy treatment plans between radiation oncologists and radiologists, with the goal of improving communication and catching errors in cancer care. **You may be eligible if...** - You are a radiation oncologist or radiologist (this study is for healthcare providers, not patients) - Your practice treats at least 3 patients per month with lung or head and neck cancer - Your practice uses a standard medical imaging software system (PACS) - You have been practicing independently for at least 6 months - You treat lung and/or head and neck cancer patients with curative-intent radiation therapy **You may NOT be eligible if...** - Your practice does not meet the minimum patient volume requirements - You do not have both a radiation oncologist and a radiologist willing to participate This is a study for medical professionals. Talk to your practice administrator to see if your clinic is eligible.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTraining and Education

Receive training and practice cases on CORRECT workflow

OTHERCommunication Intervention

Use CORRECT workflow

OTHERSurvey Administration

Ancillary studies

OTHERInterview

Ancillary studies

OTHERElectronic Health Record Review

Ancillary studies


Locations(1)

Wake Forest NCORP Research Base

Winston-Salem, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07282444


Related Trials